Latest news from Sbarro Health Research Organization (SHRO) on Newswise en-us Copyright 2025 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/plants-detect-toxins-in-wider-area-of-italy-s-land-of-fires-linked-to-high-cancer-rates/?sc=rsin /articles/plants-detect-toxins-in-wider-area-of-italy-s-land-of-fires-linked-to-high-cancer-rates/?sc=rsin Tue, 22 Apr 2025 17:40:56 EST A new scientific study has revealed alarming levels of toxic elements in the infamous 'Land of Fires' in Campania, an area known for having one of the highest cancer rates in Europe, even in zones previously considered uncontaminated. Sbarro Health Research Organization (SHRO) /articles/science-backed-exercise-therapy-improves-low-back-pain/?sc=rsin /articles/science-backed-exercise-therapy-improves-low-back-pain/?sc=rsin Fri, 18 Apr 2025 03:50:52 EST Research supports the effectiveness of a kinesiology-based method to treat lower back pain, say study authors working in collaboration with the National Research Council of Italy, and scientists at the Sbarro Health Research Organization under the leadership of its Founder and President, Antonio Giordano, M.D., Ph.D., Professor at Temple University. Sbarro Health Research Organization (SHRO) /articles/sbarro-health-research-organization-s-professor-antonio-giordano-to-attend-innovaway-s-u-s-expansion-event-in-new-york-city/?sc=rsin /articles/sbarro-health-research-organization-s-professor-antonio-giordano-to-attend-innovaway-s-u-s-expansion-event-in-new-york-city/?sc=rsin Mon, 07 Apr 2025 14:45:45 EST Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City Sbarro Health Research Organization (SHRO) /articles/the-perform-study-ai-versus-human-residents-in-cross-sectional-obstetrics-gynecology-scenarios-across-languages-and-time-constraints/?sc=rsin /articles/the-perform-study-ai-versus-human-residents-in-cross-sectional-obstetrics-gynecology-scenarios-across-languages-and-time-constraints/?sc=rsin Thu, 27 Mar 2025 08:55:16 EST The PERFORM Study: AI Versus Human Residents in Cross-Sectional Obstetrics-Gynecology Scenarios Across Languages and Time Constraints Sbarro Health Research Organization (SHRO) /articles/early-pandemic-vulnerability-to-severe-covid-identified-with-certain-immune-system-genotypes/?sc=rsin /articles/early-pandemic-vulnerability-to-severe-covid-identified-with-certain-immune-system-genotypes/?sc=rsin Wed, 19 Mar 2025 17:45:12 EST This updated analysis of the relationship between HLA and severe COVID looks at a 'case-control' study of HLA genotypes. Sbarro Health Research Organization (SHRO) /articles/precision-medicine-uses-ai-to-predict-protein-kinase-treatment-targets/?sc=rsin /articles/precision-medicine-uses-ai-to-predict-protein-kinase-treatment-targets/?sc=rsin Mon, 10 Mar 2025 17:05:44 EST Protein kinase research presents an opportunity to explore molecular targets in the body to treat diseases like cancer and autoimmune disorders. These enzymes have the potential to bind to cellular sites and inhibit dysfunctional behavior, such as the overproduction of cancerous cells and tumor formation. Sbarro Health Research Organization (SHRO) /articles/an-important-step-forward-in-precision-oncology-new-genetic-tool-predicts-chemotherapy-side-effects-before-treatment-begins/?sc=rsin /articles/an-important-step-forward-in-precision-oncology-new-genetic-tool-predicts-chemotherapy-side-effects-before-treatment-begins/?sc=rsin Wed, 26 Feb 2025 05:20:24 EST A groundbreaking pharmacogenetic tool has been developed and validated to predict chemotherapy side effects based on a patient's genetic profile. Sbarro Health Research Organization (SHRO) /articles/european-court-holds-italy-responsible-for-environmental-hazards-in-land-of-fires-shro-s-giordano-comments/?sc=rsin /articles/european-court-holds-italy-responsible-for-environmental-hazards-in-land-of-fires-shro-s-giordano-comments/?sc=rsin Mon, 17 Feb 2025 17:30:30 EST Sbarro Health Research Organization (SHRO) /articles/increasing-chemotherapy-effectiveness-with-oleanolic-acid-from-grapes/?sc=rsin /articles/increasing-chemotherapy-effectiveness-with-oleanolic-acid-from-grapes/?sc=rsin Fri, 27 Dec 2024 18:00:35 EST Researchers describe a new potential role for Oleanolic Acid as a modulator of the DNA damage response following Camptothecin treatment. Administration of Oleanolic Acid in combination with Camptothecin for cancer chemotherapy may reduce the amount of drug needed and increase the effectiveness of treatment. Sbarro Health Research Organization (SHRO) /articles/falcons-exposed-to-heavy-metals-are-a-red-flag-for-environmental-health/?sc=rsin /articles/falcons-exposed-to-heavy-metals-are-a-red-flag-for-environmental-health/?sc=rsin Tue, 26 Nov 2024 15:00:56 EST Exposure to heavy metals compromises immune functions and reduces reproductive success in the peregrine falcon (Falco peregrinus), according to a new paper published by researchers working with the Sbarro Health Research Organization (SHRO) at Temple University in collaboration with the veterinary research group of the Department of Health Sciences at Magna Graecia University of Catanzaro, Italy. Sbarro Health Research Organization (SHRO) /articles/maryland-professor-luana-colloca-recognized-with-lifetime-achievement-award/?sc=rsin /articles/maryland-professor-luana-colloca-recognized-with-lifetime-achievement-award/?sc=rsin Mon, 18 Nov 2024 10:55:50 EST The National Italian American Foundation (NIAF) and the Sbarro Health Research Organization (SHRO) named Dr. Luana Colloca the recipient of the 2024 Giovan Giacomo Giordano-NIAF Lifetime Achievement Award for Ethics and Creativity in Medical Research. Sbarro Health Research Organization (SHRO) /articles/personalized-breast-cancer-treatment-through-non-invasive-liquid-biopsy/?sc=rsin /articles/personalized-breast-cancer-treatment-through-non-invasive-liquid-biopsy/?sc=rsin Thu, 14 Nov 2024 13:35:22 EST In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable advancements in this field, significant challenges persist. Issues such as pre-analytical variability, interpretative ambiguity, and inconsistent threshold definitions hinder accurate diagnosis and subsequent treatment decisions. In this context, emerging liquid biopsy technologies present a promising solution. Sbarro Health Research Organization (SHRO) /articles/chili-peppers-exhibit-antitumor-effect-on-mesothelioma-cancer-cells/?sc=rsin /articles/chili-peppers-exhibit-antitumor-effect-on-mesothelioma-cancer-cells/?sc=rsin Tue, 05 Nov 2024 12:55:04 EST Capsaicin, the compound in chili peppers which gives them their spicy taste, may become a source of new, natural drugs for the hard-to-treat Mesothelioma type of cancer. Sbarro Health Research Organization (SHRO) /articles/nih-director-monica-m-bertagnolli-honored-with-niaf-leonardo-da-vinci-award-in-health-and-science/?sc=rsin /articles/nih-director-monica-m-bertagnolli-honored-with-niaf-leonardo-da-vinci-award-in-health-and-science/?sc=rsin Tue, 29 Oct 2024 09:35:28 EST The National Italian American Foundation (NIAF) presented its Leonardo da Vinci Award in Health and Science to National Institutes of Health (NIH) Director Monica M. Bertagnolli Saturday at the 49th annual NIAF gala in Washington, D.C. Sbarro Health Research Organization (SHRO) /articles/shro-hosts-scientific-session-at-the-national-italian-american-foundation-gala-in-washington-d-c/?sc=rsin /articles/shro-hosts-scientific-session-at-the-national-italian-american-foundation-gala-in-washington-d-c/?sc=rsin Tue, 01 Oct 2024 09:05:58 EST On October 26, 2024, the National Italian-American Foundation (NIAF) will hold its 49th annual Gala at the Omni Shoreham Hotel in Washington D.C. As part of the weekend's prestigious events, the Sbarro Health Research Organization (SHRO) will host a scientific symposium focused on advancements in pain management. Sbarro Health Research Organization (SHRO) /articles/understanding-cancer-patients-with-malnutrition-and-metabolic-dysfunction/?sc=rsin /articles/understanding-cancer-patients-with-malnutrition-and-metabolic-dysfunction/?sc=rsin Tue, 17 Sep 2024 08:05:41 EST Cancer patients frequently experience metabolic dysfunction leading to severe weight loss correlating with a poor prognosis. Causes for this dysfunction include malnutrition and cachexia, a systemic inflammation affecting brain mechanisms regulating satiety and hunger. Sbarro Health Research Organization (SHRO) /articles/pa-state-senator-aument-recognized-for-his-support-of-research-at-shro/?sc=rsin /articles/pa-state-senator-aument-recognized-for-his-support-of-research-at-shro/?sc=rsin Wed, 11 Sep 2024 10:05:12 EST Temple University's Sbarro Institute for Cancer Research and Molecular Medicine has benefited from the support of Pennsylvania State Sen. Ryan Aument since he took office in 2014. Sbarro Health Research Organization (SHRO) /articles/migrant-women-and-access-to-sexual-and-reproductive-health-services/?sc=rsin /articles/migrant-women-and-access-to-sexual-and-reproductive-health-services/?sc=rsin Wed, 11 Sep 2024 10:05:07 EST The number of people living in a different place from their place of birth is increasing year by year. Although women have always been involved in migratory movements, today they are increasingly doing so independently. Women are migrating from the Global South to higher-income countries. Sbarro Health Research Organization (SHRO) /articles/shro-scientist-named-fda-aacr-cancer-research-fellow/?sc=rsin /articles/shro-scientist-named-fda-aacr-cancer-research-fellow/?sc=rsin Fri, 30 Aug 2024 16:05:28 EST Canio Martinelli, M.D., MSc, GYN-OB resident at the University of Messina and visiting Ph.D. student in Translational Molecular Medicine and Surgery at the Sbarro Health Research Organization (SHRO), Temple University, has been honored with the 2024-2025 FDA-AACR Oncology Educational Fellowship. Sbarro Health Research Organization (SHRO) /articles/shro-award-announcement-june-28-2024/?sc=rsin /articles/shro-award-announcement-june-28-2024/?sc=rsin Wed, 03 Jul 2024 09:05:19 EST The annual Taobuk International Literary Festival held in Taormina, Sicily has announced their 2024 Taobuk Awards, naming Professor Antonio Giordano, MD, PhD, President and Founder of the Sbarro Health Research Organization (SHRO), this year's recipient of the Da Vinci Award. Sbarro Health Research Organization (SHRO)